Acme Labs Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ACME LABS, and what generic and branded alternatives to ACME LABS drugs are available?
ACME LABS has five approved drugs.
Drugs and US Patents for Acme Labs
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Acme Labs | MEMANTINE HYDROCHLORIDE | memantine hydrochloride | TABLET;ORAL | 209527-002 | May 7, 2018 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Acme Labs | MEMANTINE HYDROCHLORIDE | memantine hydrochloride | TABLET;ORAL | 209527-001 | May 7, 2018 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Acme Labs | PREGABALIN | pregabalin | CAPSULE;ORAL | 210585-006 | Dec 26, 2019 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.